| __timestamp | Perrigo Company plc | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2613100000 | 16606000 |
| Thursday, January 1, 2015 | 2891500000 | 21497000 |
| Friday, January 1, 2016 | 3228800000 | 25462000 |
| Sunday, January 1, 2017 | 2966700000 | 28195000 |
| Monday, January 1, 2018 | 2900200000 | 33078000 |
| Tuesday, January 1, 2019 | 3064100000 | 36523000 |
| Wednesday, January 1, 2020 | 3248100000 | 41455000 |
| Friday, January 1, 2021 | 2722500000 | 74400000 |
| Saturday, January 1, 2022 | 2996200000 | 101582000 |
| Sunday, January 1, 2023 | 2975200000 | 112903000 |
Unlocking the unknown
In the ever-evolving landscape of the healthcare industry, understanding cost structures is crucial. Perrigo Company plc, a global leader in over-the-counter health products, and Veracyte, Inc., a pioneer in genomic diagnostics, offer a fascinating study in contrasts. From 2014 to 2023, Perrigo's cost of revenue has shown a steady trend, peaking in 2020 with a 24% increase from 2014. Meanwhile, Veracyte's expenses have surged, reflecting a 580% rise over the same period, indicative of its rapid growth and expansion in the genomic space. This data highlights the differing strategies of a mature company versus a burgeoning innovator. As Perrigo stabilizes its costs, Veracyte's increasing expenses underscore its investment in cutting-edge technology. These insights provide a window into the financial dynamics shaping the future of healthcare.
Comparing Cost of Revenue Efficiency: AbbVie Inc. vs Veracyte, Inc.
Analyzing Cost of Revenue: Pfizer Inc. and Perrigo Company plc
Bristol-Myers Squibb Company vs Veracyte, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Incyte Corporation and Perrigo Company plc's Expenses
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Perrigo Company plc's Expenses
Cost Insights: Breaking Down Exelixis, Inc. and Perrigo Company plc's Expenses
Comparing Cost of Revenue Efficiency: Telix Pharmaceuticals Limited vs Veracyte, Inc.
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Veracyte, Inc.
Analyzing Cost of Revenue: Perrigo Company plc and Geron Corporation
Veracyte, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Veracyte, Inc. vs Agios Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Veracyte, Inc. and Evotec SE